(Q36089872)

English

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

pancreatic cyst

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Benjamin F Mann

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

John A Goetz

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Michael G House

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

C Max Schmidt

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Milos V Novotny

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

5 March 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Molecular & Cellular Proteomics

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M111.015792

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Serum biomarker panels for the detection of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Software tool for researching annotations of proteins: open-source protein annotation software with data visualization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

A compendium of potential biomarkers of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Proteomic analyses of pancreatic cyst fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Biological function of fucosylation in cancer biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Alterations in the serum glycome due to metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Practice guidelines in acute pancreatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Solid-phase permethylation of glycans for mass spectrometric analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Tumor-associated trypsin inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: its hydrolysis and protection by intraluminal factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Carbohydrate structure of human pancreatic elastase 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

23 September 2018

Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Prevalence of incidental pancreatic cysts in the adult population on MR imaging

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of cystic pancreatic masses: relative accuracy of CT and MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fucosylated type-2 chain polylactosamine antigens in human lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1074/MCP.M111.015792

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36089872&oldid=1980407963"